Latest EU News | Page 4

Analysis – Growing market opportunities for Australian wine exports to Thailand
2023 was the year of generative AI. What can we expect in 2024?
Australia-European Union FTA update
From ‘open skies’ to ‘slot-hoarding’: the turbulent world of aviation laws explained
Pesticide residue from farms and towns is ending up in fresh oysters
The NZ aviation industry is making bold climate claims – and risking anti-greenwashing litigation
Meat alternatives could feed humans more sustainably
Power of COP for co-operation, co-creation and action
Advocates Deliver Over 540,000 Signatures Demanding Increased Regulation to Combat Child Sexual Abuse Online
Hyped and expensive, hydrogen has a place in Australia’s energy transition, but only with urgent government support
Social media ads are littered with ‘green’ claims. How are we supposed to know they’re true?
Call to share all clinical trial results
Leading development agencies welcome early agreement on the Loss and Damage Fund announced at COP28
COP28 is global stocktake of climate change
Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
AFP expands its international reach in Europe
When AI gets it wrong, workers suffer
eDriving Launches New EcoReport Sustainability Reporting Solution for Fleets
Insight – Australia is key global exporter of pulses
New Zealand welcomes European Parliament vote on the NZ-EU Free Trade Agreement
AUSTRAC accepts enforceable undertaking from Gold Corporation
Climate Group responds to vote on CO2 standards for heavy trucks in the EU
Statement on Europe’s glyphosate decision
Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
Forestry Corp to pay $500,000 after removal of trees at Coopernook State Forest
Imfinzi plus chemotherapy approved in China as first immunotherapy regimen for patients with locally advanced or metastatic biliary tract cancer
Update on PACIFIC-2 Phase III trial of Imfinzi concurrently administered with platinum-based chemoradiotherapy in unresectable, Stage III non-small cell lung cancer
Livestock sustainability on menu
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III trial
Who will write the rules for AI? How nations are racing to regulate artificial intelligence
Australia signs the Bletchley Declaration at AI Safety Summit
Security Council: Bosnia and Herzegovina
ZORA real-world evidence demonstrates that Lokelma substantially increases cardiorenal patients’ chances of maintaining lifesaving RAASi therapy
Autumn Budget must restore UK climate leadership ahead of COP28
Anga Whakamua | Shaping our Futures President’s Speech
Stepping away from EU deal, right call
Farmers applaud Trade Minister for standing firm on EU
WA says bonjour to new direct flight connection with Paris
Free trade should include fair go for farmers
Fair trade, not just free trade
ERC Synergy Grant for Immunotherapy of Liver Metastases
Trade deal cheap photo opp
Major project addressing energy efficiency in existing Australian homes launches
Good deal, or no deal for Aussie farmers in Europe
Climate Group responds to ENVI Committee vote on CO2 targets for new freight trucks
Demand for fossil fuels set to plummet warns new report: Rush to renewables puts pressure on Albanese to propose new plan
Security Council: Security Council Resolutions 1160 (1998), 1199 (1998), 1203 (1998), 1239 (1999) and 1244 (1999)
Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-mutant advanced non-small cell lung cancer